KIAA0947 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.046180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.610400E-01
Normal-vs-Stage2
7.861600E-02
Normal-vs-Stage3
1.588370E-01
Normal-vs-Stage4
7.282400E-01
Stage1-vs-Stage2
1.309790E-01
Stage1-vs-Stage3
2.946200E-02
Stage1-vs-Stage4
9.636200E-01
Stage2-vs-Stage3
1.419190E-03
Stage2-vs-Stage4
1.890640E-01
Stage3-vs-Stage4
9.175700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.036640E-01
Normal-vs-AfricanAmerican
6.323600E-01
Normal-vs-Asian
6.329700E-02
Caucasian-vs-AfricanAmerican
2.268600E-01
Caucasian-vs-Asian
2.570200E-01
AfricanAmerican-vs-Asian
1.142150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.309700E-02
Normal-vs-Female
1.729620E-01
Male-vs-Female
2.637600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.084600E-01
Normal-vs-Age(41-60Yrs)
2.964200E-01
Normal-vs-Age(61-80Yrs)
5.939500E-02
Normal-vs-Age(81-100Yrs)
5.994400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.571400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.534030E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.157020E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.064100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.988500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.208600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.897930E-02
Normal-vs-Daily Drinker
7.076400E-02
Normal-vs-Weekly Drinker
1.979970E-01
Normal-vs-Occasional Drinker
1.276250E-01
Normal-vs-Social Drinker
5.179200E-01
Non Drinker-vs-Daily Drinker
5.829200E-01
Non Drinker-vs-Weekly Drinker
2.107000E-01
Non Drinker-vs-Occasional Drinker
1.161230E-01
Non Drinker-vs-Social Drinker
5.607700E-02
Daily Drinker-vs-Weekly Drinker
4.964600E-01
Daily Drinker-vs-Occasional Drinker
3.727400E-01
Daily Drinker-vs-Social Drinker
1.064210E-01
Weekly Drinker-vs-Occasional Drinker
9.345200E-01
Weekly Drinker-vs-Social Drinker
3.912800E-01
Occasional Drinker-vs-Social Drinker
3.511400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.407200E-01
Normal-vs-Grade 2
9.018800E-01
Normal-vs-Grade 3
8.352400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.357200E-01
Grade 1-vs-Grade 3
9.871000E-01
Grade 1-vs-Grade 4
6.407200E-01
Grade 2-vs-Grade 3
1.824810E-01
Grade 2-vs-Grade 4
9.018800E-01
Grade 3-vs-Grade 4
8.352400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.136300E-02
Normal-vs-NonDiabetic
9.253900E-02
Diabetic-vs-NonDiabetic
2.865800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.248990E-01
Normal-vs-NoPancreatitis
7.876000E-02
Pancreatitis-vs-NoPancreatitis
9.698600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.322820E-01
Normal-vs-N1
9.288000E-02
N0-vs-N1
6.548200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.858960E-01
Normal-vs-TP53-NonMutant
4.082600E-01
TP53-Mutant-vs-TP53-NonMutant
3.774600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
